Lumeblue (previously known as Methylthioninium chloride Cosmo) Unia Europejska - polski - EMA (European Medicines Agency)

lumeblue (previously known as methylthioninium chloride cosmo)

alfasigma s.p.a. - chlorek metylotioniny - colorectal neoplasms; colonoscopy - other diagnostic agents - lumeblue is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.

Aubagio Unia Europejska - polski - EMA (European Medicines Agency)

aubagio

sanofi winthrop industrie - teriflunomide - stwardnienie rozsiane - selektywne leki immunosupresyjne - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Apealea Unia Europejska - polski - EMA (European Medicines Agency)

apealea

inceptua ab - paklitaksel - nowotwory jajnika - antineoplastic agents, taxanes - apealea w połączeniu z karboplatinom sam jest wskazany do leczenia dorosłych pacjentów z pierwszym nawrotem платиночувствительный nabłonkowego raka jajnika, pierwotnego raka otrzewnej i jajowodów raka.

Minjuvi Unia Europejska - polski - EMA (European Medicines Agency)

minjuvi

incyte biosciences distribution b.v. - tafasitamab - lymphoma, large b-cell, diffuse - Środki przeciwnowotworowe - minjuvi is indicated in combination with lenalidomide followed by minjuvi monotherapy for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) who are not eligible for autologous stem cell transplant (asct).

Melatonin Neurim Unia Europejska - polski - EMA (European Medicines Agency)

melatonin neurim

rad neurim pharmaceuticals eec sarl - melatonina - zaburzenia inicjacji snu i utrzymania - psycholeptyki - melatonin neurim is indicated as monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over.

Teriflunomide Mylan Unia Europejska - polski - EMA (European Medicines Agency)

teriflunomide mylan

mylan pharmaceuticals limited - teriflunomide - stwardnienie rozsiane, Рецидивно-znika - leki immunosupresyjne - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Teriflunomide Accord Unia Europejska - polski - EMA (European Medicines Agency)

teriflunomide accord

accord healthcare s.l.u. - teriflunomide - stwardnienie rozsiane, Рецидивно-znika - leki immunosupresyjne selektywne leki immunosupresyjne - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).